HLA-A*0201 is associated with a better outcome after donor lymphocyte infusion for recurrent malignancy.

David Nachbaur; Olga Angelova; Klaus Loacker; Jutta Auberger; Johannes Clausen; Petra Schumacher; Günther Gastl; Brigitte Kircher

doi:10.1111/j.1600-0609.2008.01157.x

HLA-A*0201 is associated with a better outcome after donor lymphocyte infusion for recurrent malignancy.

David Nachbaur, Olga Angelova, Klaus Loacker, Jutta Auberger (Co-Autor/-in), Johannes Clausen, Petra Schumacher, Günther Gastl, Brigitte Kircher

Publikation: Beitrag in Fachzeitschrift › Letter to the editor › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	77-78
Fachzeitschrift	EUROPEAN JOURNAL OF HAEMATOLOGY
Jahrgang	82
Ausgabenummer	1
DOIs	https://doi.org/10.1111/j.1600-0609.2008.01157.x
Publikationsstatus	Veröffentlicht - 2009

Zugriff auf Dokument

10.1111/j.1600-0609.2008.01157.x

Dieses zitieren

Nachbaur, D., Angelova, O., Loacker, K., Auberger, J., Clausen, J., Schumacher, P., Gastl, G., & Kircher, B. (2009). HLA-A*0201 is associated with a better outcome after donor lymphocyte infusion for recurrent malignancy. EUROPEAN JOURNAL OF HAEMATOLOGY , 82(1), 77-78. https://doi.org/10.1111/j.1600-0609.2008.01157.x

Nachbaur, David ; Angelova, Olga ; Loacker, Klaus et al. / HLA-A*0201 is associated with a better outcome after donor lymphocyte infusion for recurrent malignancy. in: EUROPEAN JOURNAL OF HAEMATOLOGY 2009 ; Jahrgang 82, Nr. 1. S. 77-78.

@article{e6739b602298483e9878c0df919c5cf1,

title = "HLA-A*0201 is associated with a better outcome after donor lymphocyte infusion for recurrent malignancy.",

keywords = "MINOR HISTOCOMPATIBILITY ANTIGENS, STEM-CELL TRANSPLANTATION, MYELOID-LEUKEMIA, RELAPSE",

author = "David Nachbaur and Olga Angelova and Klaus Loacker and Jutta Auberger and Johannes Clausen and Petra Schumacher and G{\"u}nther Gastl and Brigitte Kircher",

year = "2009",

doi = "10.1111/j.1600-0609.2008.01157.x",

language = "English",

volume = "82",

pages = "77--78",

journal = "EUROPEAN JOURNAL OF HAEMATOLOGY ",

issn = "0902-4441",

publisher = "Wiley Verlag ",

number = "1",

}

Nachbaur, D, Angelova, O, Loacker, K, Auberger, J, Clausen, J, Schumacher, P, Gastl, G & Kircher, B 2009, 'HLA-A*0201 is associated with a better outcome after donor lymphocyte infusion for recurrent malignancy.', EUROPEAN JOURNAL OF HAEMATOLOGY , Jg. 82, Nr. 1, S. 77-78. https://doi.org/10.1111/j.1600-0609.2008.01157.x

HLA-A*0201 is associated with a better outcome after donor lymphocyte infusion for recurrent malignancy. / Nachbaur, David; Angelova, Olga; Loacker, Klaus et al.
in: EUROPEAN JOURNAL OF HAEMATOLOGY , Jahrgang 82, Nr. 1, 2009, S. 77-78.

Publikation: Beitrag in Fachzeitschrift › Letter to the editor › Begutachtung

TY - JOUR

T1 - HLA-A*0201 is associated with a better outcome after donor lymphocyte infusion for recurrent malignancy.

AU - Nachbaur, David

AU - Angelova, Olga

AU - Loacker, Klaus

AU - Auberger, Jutta

AU - Clausen, Johannes

AU - Schumacher, Petra

AU - Gastl, Günther

AU - Kircher, Brigitte

PY - 2009

Y1 - 2009

KW - MINOR HISTOCOMPATIBILITY ANTIGENS

KW - STEM-CELL TRANSPLANTATION

KW - MYELOID-LEUKEMIA

KW - RELAPSE

U2 - 10.1111/j.1600-0609.2008.01157.x

DO - 10.1111/j.1600-0609.2008.01157.x

M3 - Letter to the editor

C2 - 18801059

SN - 0902-4441

VL - 82

SP - 77

EP - 78

JO - EUROPEAN JOURNAL OF HAEMATOLOGY

JF - EUROPEAN JOURNAL OF HAEMATOLOGY

IS - 1

ER -

Nachbaur D, Angelova O, Loacker K, Auberger J, Clausen J, Schumacher P et al. HLA-A*0201 is associated with a better outcome after donor lymphocyte infusion for recurrent malignancy. EUROPEAN JOURNAL OF HAEMATOLOGY . 2009;82(1):77-78. doi: 10.1111/j.1600-0609.2008.01157.x